Elite Pharmaceuticals Inc (ELTP)

[rrr2003]

Thank you for the info.

I guess the underlying message I was trying to convey was that the one time milestone payments are not considered to be one of those ongoing activities of ELTP that produce revenues (i.e. sales of products, manufacturing fees, etc.). Milestone payments are not regular ongoing events nor are they a revenue stream. The misleading implication is that there will be a 2-3 mil shortfall from the previous fiscal period resulting in a financially unstable business. This shortfall, if it occurs, will be the result of diminished milestone payments and in no way reflects financial weakness. This is why Nasrat made reference to the approximate 10 mil annualized revenues to be expected.

Of interest, I did note (if I am reading the addendum notes correctly)in the last 10K the milestone payments were lumped in with the licensing fee revenues.